Great!
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.54%
!
$14.18

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.18 |
Change
0.870(6.54%) |
Mkt cap ! $1.758B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $8.058M | 581.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 457 | $14.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.32 | 269 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 774 | 14.230 |
4 | 491 | 14.220 |
5 | 598 | 14.210 |
4 | 969 | 14.200 |
4 | 1199 | 14.190 |
Price($) | Vol. | No. |
---|---|---|
14.260 | 3460 | 7 |
14.270 | 1449 | 6 |
14.280 | 1893 | 6 |
14.290 | 1955 | 6 |
14.300 | 1294 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online